The verified answer
As of Oct 2026, DEPLOY verifies Quantum Surgical: 1 model, 6 deployments across 4 regions, $86.9M raised, 4 active incidents. 1 source back the record.
Quantum Surgical holds 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 1 filingsCategorySurgical robots
Overview
French medical robotics company developing the Epione robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former Medtech SA engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.
Verified record
- Verified deployments
- 6 deployments on file
- Active incidents
- 4 incidents on file
Valuation of record
DEPLOY VERIFIEDPriced roundOther post-money
Key facts
FDA cleared
CE marked
Acquired NeuWave Medical
CEO
Group CEO
Co-founders
FDA clearance
CE mark
Parent company
Patients treated
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company Quantum Surgical has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1NeuWave Medical1× joint
- 2Precision IO Group1× joint
Most recent
- Quantum Surgical x NeuWave Medical2026-02-24with NeuWave Medicaloperating
Quantum Surgical on the deployment map
View the global map6 verified deployments across 4 regions, newest verified Dec 2025. Explore where Quantum Surgical's robots are operating, by place and type.
- operationalEpione at Leeds, UK →United Kingdom · verified Dec 2025
- operationalEpione at London →United Kingdom · verified Jun 2025
- operationalEpione at Chicago →Illinois · verified Jan 2025
- operationalEpione at Marseille, France →Western Europe · verified Mar 2024
- operationalEpione at Miami →Florida · verified May 2023
- operationalEpione at Villejuif, France →Western Europe · verified Sep 2020
View the full Quantum Surgical deployment record →
Relationships
Current leadership (4)
- Bertin Nahum President & Co-founderreported, not verified
- Kurt Azarbarzin CEO, Precision IO Groupreported, not verified
- Lucien Blondel CTO & Co-founderreported, not verified
- Fernand Badano Managing Director & Co-founderreported, not verified
Founders (3)
- Bertin Nahumcofounder
previously at Medtech SA
- Lucien Blondelcofounder
- Fernand Badanocofounder
Safety record
1 recall and 3 incidents on record (1 critical, 1 moderate, 2 minor). Most recent: Mar 2026.
Most recent: Mar 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Quantum Surgical (4)
- Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers2026-03-26 · Regulatory action
- FDA clears Quantum Surgical Epione robot for abdominal tumor ablation2025-03-26 · Regulatory action
- FDA Class 2 recall of Epione needle guide component due to rust2024-08-05 · Recall
- Patient death during Epione-assisted liver cancer ablation procedure in France2023-11-10 · Fatality
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Quantum Surgical6 deployments
Recent coverage
Quantum Surgical in third-party press
Peers
41 peers across 1 segment. Every Quantum Surgical competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Butterfly Networkdirect competitor(inferred)strong
- Cornerstone Roboticsdirect competitor(inferred)strong
- Edge Medical Roboticsdirect competitor(inferred)strong
- ForSight Roboticsdirect competitor(inferred)strong
- LDR Holding Corporationdirect competitor(inferred)strong
- LEM Surgicaldirect competitor(inferred)strong
Financial state
- Total funding
- $86.9M
- Employees
- 140
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
1 total · 1 operating
Every company Quantum Surgical has built with, alongside the ones only announced in a press release.
Most recent
- Quantum Surgical x NeuWave Medical2026-02-24with NeuWave Medicaloperating
Most-frequent partners
- 1NeuWave Medical1× joint
- 2Precision IO Group1× joint
All 1 partnerships
open in the atlas →- Quantum Surgical x NeuWave MedicalwithNeuWave Medical,Precision IO Groupinvestment2026-02-24operating
Funding rounds (4)
Quantum Surgical’s 4 disclosed rounds, $87M in total, oldest to newest.
- Other2024-07-11
$33M(reported) · $165M post
Investors: European Investment Bank
- Series B2021-10-19
$48M(reported) · $384M post
Investors: Ally Bridge Group, European Investment Bank, Bpifrance, Caisse d'Epargne Languedoc-Roussillon
- Series A2018-06-11
$6M(reported) · $35M post
Investors: Ally Bridge Group, Muhan Investment Company
- Seed2016-12-16
$53,000(reported) · $0M post
Regulatory filings (1)
Timeline
Every recorded move in Quantum Surgical’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
PartnershipQuantum Surgical x NeuWave Medical
2026-02-24Quantum Surgical acquired NeuWave Medical, whose microwave ablation technology is used in 70% of top US cancer centers. Both operate as subsidiaries of newly created Precision IO Group, led by Kurt Azarbarzin. The combination pairs Epione's robotic platform with NeuWave's ablation technology.
Funding roundOther funding round
2024-07-11Other raising $33000000
Funding roundSeries B funding round
2021-10-19Series B raising $48000000
Funding roundSeries A funding round
2018-06-11Series A raising $5870000
Funding roundSeed funding round
2016-12-16Seed raising $53000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 6, 2026
Added to the verified registry
- Incident recordedMar 26, 2026
Quantum Surgical receives FDA 510(k) clearance for Epione robot for all abdominal cancers
- Deployment verifiedVerifiedDec 4, 2025
Epione at Leeds, UK
- Deployment verifiedVerifiedJun 10, 2025
Epione at London
- Incident recordedMar 26, 2025
FDA clears Quantum Surgical Epione robot for abdominal tumor ablation
Sources (1)
Common questions
What is Quantum Surgical?
What does Quantum Surgical make?
Is Quantum Surgical publicly traded?
Who competes with Quantum Surgical?
Who is the CEO of Quantum Surgical?
How can I invest in Quantum Surgical?
Where is Quantum Surgical headquartered?
How much funding has Quantum Surgical raised?
Who owns Quantum Surgical?
Where does Quantum Surgical operate robots?
How many robots has Quantum Surgical deployed?
Is Quantum Surgical a top robotics company?
Are there any incidents involving Quantum Surgical?
Is Quantum Surgical safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Quantum Surgical.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
In the press
Recent coverage mentioning Quantum Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
Quantum Surgical Acquires NeuWave Medical, Inc.
Quantum Surgical acquired NeuWave Medical, whose microwave ablation technology is used in 70% of top US cancer centers, forming Precision IO Group with Kurt Azarbarzin as CEO.
King's College Hospital Becomes First in United Kingdom to Adopt Epione
King's College Hospital NHS Foundation Trust in London became the first UK hospital to install the Epione robotic platform for percutaneous tumor ablation.
FDA clears Quantum Surgical Epione robot for all abdominal cancers
Quantum Surgical received FDA 510(k) clearance for its Epione robotic-assisted platform for all abdominal cancer tumor ablation treatments.
Rush University System for Health Becomes First in Midwest to Acquire Quantum Surgical Robotic Platform
Rush University System for Health in Chicago became the first Midwest hospital to acquire the Epione robotic platform for treating abdominal cancer tumors.
France: Medical robotics company Quantum Surgical gets EIB loan to advance tumour treatment
EIB provided EUR 30M loan to Quantum Surgical to accelerate worldwide commercialization of Epione for treating abdominal and lung cancer, bringing total EIB financing to EUR 45M.
Quantum Surgical Secures 40 Million Euros to Support the Commercial Launch of Epione
Quantum Surgical raised EUR 40M (USD 48M) led by Ally Bridge Group with EUR 20M, plus EIB, Bpifrance, and Caisse d'Epargne, bringing total funding to EUR 50M.
Machine-readable surfaces
- Markdown mirror: /companies/quantum-surgical.md
- RSS feed: /companies/quantum-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed
- Revision history: /companies/quantum-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
Video
Liver cancer ranks amongst the three most deadly cancers. Ideally, in order to ensure a high survival rate, early mini-invasive treatment is required on tumor
Discover a groundbreaking achievement in cancer care at Miami Cardiac and Vascular Institute and Miami Cancer Institute, part of Baptist Health South Florida. A
Quantum Surgical developed Epione®, a robot dedicated to the curative treatment of early-stage tumors. Epione® assists physicians like Professor DeBaere with c
Want to see more? SUBSCRIBE to watch the latest podcasts: https://bit.ly/2UgRa2S Connect with Joe: LINKEDIN: https://www.linkedin.com/in/joemullings FACEBOOK:
"Plenary sessions - A time for big technological bets - Robotics and automation Bertin NAHUM, President and Founder, Quantum Surgical More info about DigiWorld
In this interview, Bertin Nahum, CEO of Quantum Surgical, explains how its now commercial system Epione will advance cancer treatment with high-powered surgical
Bertin Nahum on Scaling Surgical Robotics for Cancer Care In this episode, Bertin Nahum, President and co-founder of Quantum Surgical, shares his journey from
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions
Bertin Nahum, CEO @Quantum Surgical in conversation with Anne-Helene Illich, Co-head Private Wealth Management Paris, @GoldmanSachs.
In the first episode, Nick speaks with Dr Lucien Blondel all about his journey and passion for surgical robotic development! Dr Lucien Blondel is the CTO and C
Heat Index
Category contender77/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Quantum Surgical draws attention at the 38th percentile but verifies reality at the 88th percentile among surgical robots. Hype Gap -49.8, 42nd widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Strong deployment footprint with 6 operational sites across 6 countries. Thin IP estate relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 6, 2026